Saw palmetto can improve symptoms for men with urinary problems

December 12, 2001

A six-month-long carefully controlled study by physicians at the University of Chicago, published in the December issue of the journal Urology, shows that the herbal remedy saw palmetto can improve symptoms for men with lower urinary tract problems, but that it has no significant impact on urinary flow rates, quality of life, or sexual function.

Although several smaller, briefer and uncontrolled trials of saw palmetto (serona repens) have implied benefits from this herb, many physicians have remained skeptical.

Men with urinary symptoms -- such as an enlarged prostate, which can interfere with their efforts to empty their bladders -- have not shared these doubts. They spend more than $140 million a year on herbal preparations containing saw palmetto, making it one of the 10 best-selling herbal remedies.

"Our study provides the best evidence to date that saw palmetto can have a beneficial effect," said Glenn Gerber, M.D., associate professor of surgery at the University of Chicago and director of the study.

Gerber and colleagues at the University of Chicago and at the Dekalb Clinic, in Dekalb, Illinois, enrolled 94 men who complained of urinary retention in the trial. During the first month of the study all participants received a placebo capsule twice a day. After the first month, nine men who reported considerable improvement were removed from the trial.

The remaining 85 men were randomly selected to receive two capsules a day of either saw palmetto (provided by Nutraceutical Corp., Ogden, Utah) or a placebo.

After the one-month placebo "run-in period,' the study subjects filled out a standardized questionnaire about their urinary symptoms, a second questionnaire about sexual function, and a third questionnaire about quality of life. They also had their urinary flow rates measured. The tests were repeated two, four and six months into the trial.

After six months on the mediction, the men who received saw palmetto had a 4.4-point decrease (improvement) in their urinary symptom score, from an average of 16.7 down to 12.3. Men who received only the placebo also had a reduction but of only half the size, 2.2 points, from 15.8 down to 13.6.

There were no significant differences between the two groups in the other measurements. Peak urinary flow rates improved slightly in both groups. Self-assessed quality of life improved slightly in both groups. There was no change in sexual function.

This may not provide the final word on saw palmetto, which has not yet been compared with standard medications for an enlarged prostate, but it does "tell doctors how to talk to patients about this supplement," said Gerber. "Saw palmetto clearly offers symptomatic benefit as compared with placebo controls."

"We can tell patients that this appears to be a safe, well-tolerated substance that can produce short-term improvement of urinary symptoms," said Gerber. "But we also need to point out that we don't know why it works, and that the dose can vary widely and unpredictably in over-the-counter preparations, which may also include other untested herbal supplements."
-end-


University of Chicago Medical Center

Related Placebo Articles from Brightsurf:

Effect of fluvoxamine vs placebo on clinical deterioration in outpatients with symptomatic COVID-19
This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects, versus placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reaction-confirmed mild COVID-19 illness.

Hydroxychloroquine no more effective than placebo in preventing COVID-19
Clinical trial with COVID-19 testing of participants shows health care workers in contact with coronavirus patients who took hydroxychloroquine each day did not reduce their rate of infection.

Compared to placebo, vitamin D has no benefit for severe asthma attacks
Contrary to earlier observational results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

UMN trial shows hydroxychloroquine has no benefit over placebo in preventing COVID-19
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

The placebo effect and psychedelic drugs: tripping on nothing?
A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone.

Methotrexate reduces joint damage progression over placebo in erosive hand OA
According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients.

Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain.

Probiotic no better than placebo for acute gastroenteritis in children
While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo.

Most common shoulder operation is no more beneficial than placebo surgery
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.

Read More: Placebo News and Placebo Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.